MX339461B - Polipeptidos y composiciones inmunizantes que contienen polipeptidos grampositivos y metodos de uso. - Google Patents

Polipeptidos y composiciones inmunizantes que contienen polipeptidos grampositivos y metodos de uso.

Info

Publication number
MX339461B
MX339461B MX2011009949A MX2011009949A MX339461B MX 339461 B MX339461 B MX 339461B MX 2011009949 A MX2011009949 A MX 2011009949A MX 2011009949 A MX2011009949 A MX 2011009949A MX 339461 B MX339461 B MX 339461B
Authority
MX
Mexico
Prior art keywords
polypeptides
methods
compositions containing
gram positive
immunizing compositions
Prior art date
Application number
MX2011009949A
Other languages
English (en)
Other versions
MX2011009949A (es
Inventor
Lisa L Herron-Olson
Drew M Catron
Original Assignee
Epitopix Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitopix Llc filed Critical Epitopix Llc
Publication of MX2011009949A publication Critical patent/MX2011009949A/es
Publication of MX339461B publication Critical patent/MX339461B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/38—Antigens from snakes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a una composición caracterizada porque comprende: un polipéptido aislado que comprende la secuencia de aminoácidos de SEQ ID NO: 397, con la condición de que si el polipéptido aislado incluye aminoácidos adicionales en la terminal amino, los aminoácidos adicionales incluyan por lo menos dos modificaciones de aminoácido en comparación con los aminoácidos 1-26 de SEC ID NO: 399.
MX2011009949A 2009-03-23 2010-03-23 Polipeptidos y composiciones inmunizantes que contienen polipeptidos grampositivos y metodos de uso. MX339461B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21077209P 2009-03-23 2009-03-23
PCT/US2010/028326 WO2010111273A1 (en) 2009-03-23 2010-03-23 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use

Publications (2)

Publication Number Publication Date
MX2011009949A MX2011009949A (es) 2011-10-06
MX339461B true MX339461B (es) 2016-05-27

Family

ID=42781438

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011009949A MX339461B (es) 2009-03-23 2010-03-23 Polipeptidos y composiciones inmunizantes que contienen polipeptidos grampositivos y metodos de uso.

Country Status (14)

Country Link
US (2) US9932373B2 (es)
EP (1) EP2411046B1 (es)
JP (2) JP2012521441A (es)
KR (4) KR101770321B1 (es)
CN (1) CN105582524A (es)
AR (1) AR075933A1 (es)
AU (1) AU2016201992B2 (es)
BR (1) BRPI1011856A2 (es)
CA (1) CA2756313A1 (es)
IL (2) IL215330A (es)
MX (1) MX339461B (es)
NZ (2) NZ595231A (es)
WO (1) WO2010111273A1 (es)
ZA (1) ZA201106959B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2586125T3 (es) 2005-02-14 2016-10-11 Epitopix, Llc Polipéptidos de Staphylococcus aureus y métodos de uso
JP2012521441A (ja) 2009-03-23 2012-09-13 エピトピックス，リミティド ライアビリティ カンパニー ポリペプチド及びグラム陽性ポリペプチドを含有する免疫化組成物並びにこれらの使用方法
AU2013202253B2 (en) * 2009-04-14 2015-03-19 Novartis Ag Compositions for immunising against Staphylococcus aureus
US9724658B2 (en) * 2011-03-28 2017-08-08 Fast & Fluid Management B.V. Method of homogenizing a liquid
US8753643B1 (en) 2012-04-11 2014-06-17 Life-Science Innovations, Llc Spray dried compositions and methods of use
US20170023569A1 (en) * 2014-01-10 2017-01-26 University Of Rochester Diagnostic device and method for detection of staphylococcus infection
JP7222711B2 (ja) 2015-07-10 2023-02-15 エピトピックス， エルエルシー タンパク質及びｋｌｅｂｓｉｅｌｌａタンパク質を含有する免疫化組成物ならびにその使用方法
WO2018072031A1 (en) * 2016-10-21 2018-04-26 Socpra Sciences Et Génies S.E.C. Vaccine constructs and uses thereof against staphylococcus infections

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981685A (en) 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US5554372A (en) 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US5292869A (en) 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
ATE352314T1 (de) 1994-02-09 2007-02-15 Epitopix Llc Aktive immunisierung gegen ein siderophores rezeptorprotein
US5830479A (en) 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US5538733A (en) 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6403337B1 (en) 1996-01-05 2002-06-11 Human Genome Sciences, Inc. Staphylococcus aureus genes and polypeptides
ES2252785T3 (es) 1996-05-16 2006-05-16 THE TEXAS A&M UNIVERSITY SYSTEM Composiciones proteinicas fijadoras de colageno y metodos de utilizacion.
US6680195B1 (en) 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
CA2404260A1 (en) * 2000-03-21 2001-09-27 Elitra Pharmaceuticals, Inc. Identification of essential genes in prokaryotes
AT410173B (de) 2000-06-08 2003-02-25 Cistem Biotechnologies Gmbh Antigene zusammensetzung
ATE322288T1 (de) 2001-01-03 2006-04-15 Epitopix Llc Zusammensetzungen zur immunisierung sowie deren verwendung
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
GB0107661D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
EP2320233A1 (en) 2001-06-15 2011-05-11 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
WO2003020875A2 (en) 2001-06-17 2003-03-13 D-Squared Biotechnologies, Inc. Staphylococci surface-exposed immunogenic polypeptides
US6720160B2 (en) 2001-10-11 2004-04-13 Helica Biosystems, Inc. Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
AU2003254555A1 (en) 2002-07-26 2004-02-23 Intercell Ag S. aureus antigene
NZ582566A (en) 2003-09-19 2010-11-26 Epitopix Llc Metal regulated polypeptides and methods of use from campylobacter spp.
JP2008508855A (ja) 2004-04-27 2008-03-27 インターツェル・アクチェンゲゼルシャフト Ｔｄ抗原
CA2576247C (en) 2004-08-26 2016-08-30 The University Of Western Ontario Pharmaceutical compositions comprising inhibitors of iron transport, and method of identifying iron transport inhibitors, in staphylococcus aureus
KR20070085457A (ko) 2004-10-25 2007-08-27 더 유니버시티 오브 웨스턴 온타리오 스태필로코쿠스 아우레우스의 철에 의해 조절되는 표면결정인자 ＩｓｄＡ, ＩｓｄＢ, 및 ＩｓｄＣ 기재 백신,조성물 및 방법
ES2586125T3 (es) 2005-02-14 2016-10-11 Epitopix, Llc Polipéptidos de Staphylococcus aureus y métodos de uso
US8021885B2 (en) 2006-10-11 2011-09-20 Evonik Rohmax Additives Gmbh Method for the determination of the oxidative stability of a lubricating fluid
JP2012521441A (ja) 2009-03-23 2012-09-13 エピトピックス，リミティド ライアビリティ カンパニー ポリペプチド及びグラム陽性ポリペプチドを含有する免疫化組成物並びにこれらの使用方法

Also Published As

Publication number Publication date
IL215330A (en) 2016-12-29
EP2411046A1 (en) 2012-02-01
IL215330A0 (en) 2011-12-29
ZA201106959B (en) 2012-06-27
US20180237481A1 (en) 2018-08-23
KR101770321B1 (ko) 2017-09-05
KR20120005471A (ko) 2012-01-16
JP2012521441A (ja) 2012-09-13
MX2011009949A (es) 2011-10-06
EP2411046A4 (en) 2012-09-19
CN105582524A (zh) 2016-05-18
NZ614557A (en) 2015-03-27
US9932373B2 (en) 2018-04-03
CN102448489A (zh) 2012-05-09
AU2016201992A1 (en) 2016-04-21
CA2756313A1 (en) 2010-09-30
KR20150093774A (ko) 2015-08-18
EP2411046B1 (en) 2017-12-06
AR075933A1 (es) 2011-05-04
KR101684292B1 (ko) 2016-12-08
JP2015164949A (ja) 2015-09-17
KR20160114744A (ko) 2016-10-05
BRPI1011856A2 (pt) 2020-11-03
IL248523A0 (en) 2016-12-29
NZ595231A (en) 2014-03-28
US20120034258A1 (en) 2012-02-09
WO2010111273A1 (en) 2010-09-30
AU2010229498A1 (en) 2011-10-13
JP6092933B2 (ja) 2017-03-08
AU2016201992B2 (en) 2018-02-15
KR20160064237A (ko) 2016-06-07

Similar Documents

Publication Publication Date Title
HK1117746A1 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
MX341825B (es) Compuestos de heteroarilo y usos de los mismos.
MX356282B (es) Composiciones y metodos que comprenden variantes de proteasa.
MX339461B (es) Polipeptidos y composiciones inmunizantes que contienen polipeptidos grampositivos y metodos de uso.
MX2014001717A (es) Composiciones inmunoterapeuticas de levadura-mucina 1 (muc1) y usos de las mismas.
MY181898A (en) Heterocyclic compounds and uses thereof
MX2007008723A (es) Polipeptidos de yersinia spp y metodos de uso.
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MX345909B (es) Anticuerpos anti-fgfr3 y métodos que los utilizan.
MX350661B (es) Composiciones inmunoterapeuticas de levadura-brachyuri.
SG179085A1 (en) Pi3 kinase inhibitors and uses thereof
MX2010006576A (es) Composiciones y metodos para producir isopreno.
EP2569330A4 (en) CHLOROTOXINE VARIANTS, CONJUGATES, AND METHODS OF USE THEREOF
MX2011010012A (es) NUEVOS ANTICUERPOS ANTI-A5ß1 Y SUS USOS.
MX2018000395A (es) Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso.
MX358864B (es) Polipeptidos antibacterianos quimericos.
SG11202107690SA (en) Methods, uses & compositions
EP4023243A3 (en) Compositions and methods for treating celiac sprue disease
IN2012DN03404A (es)
PH12015501099A1 (en) Synbiotic composition and use thereof
MY149433A (en) Nutritional compositions containing punicalagins
MX2011013790A (es) Derivados de flavina.
MY165088A (en) Pharmaceutical compositions comprising alisporivir
WO2012051126A3 (en) Anti-inflammatory macrolides
MX2013000539A (es) Nuevas formulaciones de analogos 14-epi de la vitamina d.

Legal Events

Date Code Title Description
FG Grant or registration